Our results revealed that the PEPT1/MAP4K4/G3BP2 signaling axis is essential for HCC growth and metastasis, and this mechanism may serve as a novel therapeutic target for clinical application in patients with metastatic HCC in the future. Here, MAP4K4 is linked to hepatocellular carcinoma.